TherapeuticsMD | TXMD - Equity Capital And Reserves


TherapeuticsMD reported $27.67M in Equity Capital and Reserves for its fiscal quarter ending in June of 2024.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Novo Nordisk DKK 26.56B 111.98B Jun/2025
Pfizer USD 90.1B 3.63B Mar/2026
TherapeuticsMD USD 27.67M 990K Jun/2024